Evidence map›Paper›PMID 40346509›Full record

ArticleBMC public health2025

Timely vaccination with valid doses in a high coverage country, Oman.

Prakash Kp, Bader Al-Rawahi, Noura Al-Farsi, Mariyam Al-Shaibi, Athari Al-Jahwari, Bader Al-Abri, Seif Al-Abri, Amal Al-Maani

Abstract read
In one paragraph

Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Prakash Kp *Department of Communicable diseases, Centre for disease control and prevention, Ministry of Health, Muscat, PO Box 393, Postal Code 100, Sultanate of Oman. drprakashkp@gmail.com.ORCID http://orcid.org/0000-0001-9768-5293
Bader Al-Rawahi *Department of Communicable diseases, Centre for disease control and prevention, Ministry of Health, Muscat, PO Box 393, Postal Code 100, Sultanate of Oman.
Noura Al-FarsiDepartment of Communicable diseases, Centre for disease control and prevention, Ministry of Health, Muscat, PO Box 393, Postal Code 100, Sultanate of Oman.ORCID http://orcid.org/0009-0006-5576-9927
Mariyam Al-ShaibiDepartment of Communicable diseases, Centre for disease control and prevention, Ministry of Health, Muscat, PO Box 393, Postal Code 100, Sultanate of Oman.
Athari Al-JahwariDepartment of Communicable diseases, Centre for disease control and prevention, Ministry of Health, Muscat, PO Box 393, Postal Code 100, Sultanate of Oman.
Bader Al-AbriDepartment of Surveillance, Centre for disease control and prevention, Ministry of Health, Muscat, Sultanate of Oman.
Seif Al-AbriCentre for disease control and prevention, Ministry of Health, Muscat, Sultanate of Oman.ORCID http://orcid.org/0000-0002-2669-6814
Amal Al-MaaniCentre for disease control and prevention, Ministry of Health, Muscat, Sultanate of Oman.ORCID http://orcid.org/0000-0001-8322-8331

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOman has achieved consistently high national immunization coverage; however, the timeliness and validity of vaccine administration remain under-assessed. This study evaluated the timeliness and validity of routine childhood vaccinations to provide a more comprehensive understanding of immunization program performance.

methodsA cross-sectional survey was conducted using WHO cluster sampling, targeting children under five across all 11 governorates and 61 districts in Oman. Data from 17,501 children were collected using the Epicollect5 app and verified through immunization cards and health records. Descriptive statistics, chi-square tests, and WHO operational definitions were used to assess crude coverage, valid doses, timeliness, and dropout rates.

resultsCrude national vaccination coverage was high (94.4-99.9%), with 98.7% of children fully immunized. However, only 78% received valid vaccinations, indicating missed or delayed doses. Timely vaccination rates decreased with age, with notable delays at 18 months. Invalid vaccination rates ranged from 3.3% at birth to 28.1% at 18 months, with significant district-level variation. Dropout rates slightly increased with age, peaking in Muscat and Dhofar.

conclusionsOman achieves high vaccination coverage; however, a noteworthy number of children receive invalid doses. This highlights the urgent need to educate parents and healthcare providers on timely administration of valid doses. Assessing mild illnesses and promptly administering vaccinations can improve complete vaccination rates with valid doses.

Indexed as

Immunization ProgramsImmunization ScheduleVaccinationVaccination CoverageChild, PreschoolCross-Sectional StudiesFemaleHumansInfantInfant, NewbornMaleOmanTime FactorsCoverage surveyFully vaccinatedImmunization coverageOmanVaccination coverageValid doses

Identifiers

PMID40346509
PMCPMC12063389

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.